FDA Approves Unknown Drug — STRIDES PHARMA

# FDA Approves ANDA for Strides Pharma Strides Pharma has received FDA approval for ANDA 202075, expanding its generic drug portfolio and positioning the company to capture market share in an additional therapeutic category. The approval strengthens Strides Pharma's competitive standing in the generic pharmaceutical market and is expected to contribute to revenue growth through increased product offerings to healthcare providers and patients seeking cost-effective treatment alternatives.